SCIEGEN PHARMS INC FDA Approval ANDA 203561

ANDA 203561

SCIEGEN PHARMS INC

FDA Drug Application

Application #203561

Application Sponsors

ANDA 203561SCIEGEN PHARMS INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL12.5MG0HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-01-14

Submissions Property Types

ORIG1Null17

TE Codes

001PrescriptionAB

CDER Filings

SCIEGEN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203561
            [companyName] => SCIEGEN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"12.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/14\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-01-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.